SCHEMBL2705920

SCHEMBL2705920

Cc1cc(C=CC(=O)O)ccc1CO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.51
▸ KDM4E B2RXH2 8/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ AKR1B10 O60218 3/20 0.50
▸ AKR1B1 P15121 3/20 0.50
▸ MAPK1 P28482 3/20 0.50
▸ CA12 O43570 3/20 0.50
▸ CA1 P00915 3/20 0.50
▸ CA2 P00918 3/20 0.50
▸ CA3 P07451 3/20 0.50
▸ CA4 P22748 3/20 0.50
▸ CA6 P23280 3/20 0.50
▸ CA5A P35218 3/20 0.50
▸ CA7 P43166 3/20 0.50
▸ CA9 Q16790 3/20 0.50
▸ CA14 Q9ULX7 3/20 0.50
▸ CA5B Q9Y2D0 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ GAA P10253 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705918 1.00 EGFR (0.51) EGFRKDM4EALDH1A1HSD17B10AKR1B10
SCHEMBL10149459 0.87 AKR1C3 (0.52) EGFRKDM4EALDH1A1HSD17B10AKR1B10
SCHEMBL10898081 0.84 EGFR (0.56) EGFRKDM4EALDH1A1HSD17B10AKR1B10
SCHEMBL10898075 0.84 EGFR (0.56) EGFRKDM4EALDH1A1HSD17B10AKR1B10
SCHEMBL24844874 0.81 TTR (0.62) CA12CA1CA2CA7CA9
SCHEMBL14389635 0.81 KDM4E (0.66) EGFRKDM4EALDH1A1HSD17B10AKR1B10
SCHEMBL111230 0.80 KDM4E (0.58) KDM4EALDH1A1HSD17B10AKR1B10AKR1B1
SCHEMBL584596 0.80 KDM4E (0.58) KDM4EALDH1A1HSD17B10AKR1B10AKR1B1
SCHEMBL22070868 0.80 EGFR (0.51) EGFRKDM4EALDH1A1HSD17B10AKR1B10
SCHEMBL11128501 0.79 CYP3A4 (0.46) KDM4EALDH1A1MAPK1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 — — WO disclosed
Send feedback